ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Lupeng Pharmaceutical Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 20 studies whose lead sponsor is Lupeng Pharmaceutical Ltd. or one of 2 companies grouped under it. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Lupeng Pharmaceutical with BeOne Medicines and AstraZeneca →

Pipeline: 2 programs

Each counted once: 2 with a study Lupeng Pharmaceutical Ltd. leads registered in the last two years.

  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Lupeng Pharmaceutical Ltd.’s own registered studies; Lupeng Pharmaceutical Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Lupeng Pharmaceutical Ltd.’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Lupeng Pharmaceutical Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 20 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1260%
  • Under way, not recruiting315%
  • Completed525%

Phase

  • Phase 114
  • Phase 25
  • Phase 32

Where

  • China16
  • United States4
  • Spain1
  • France1

Over the years

  1. 20
  2. 21
  3. 22
  4. 23
  5. 24
  6. 25
  7. 726

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Lupeng Pharmaceutical Ltd.

  • Guangzhou Lupeng Pharmaceutical Company LTD.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    16 studies →
  • Newave Pharmaceutical Inc
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →

Studies

Recruiting first, then most recently updated. Showing 20 of 20.